NR-45864金黄色葡萄球菌,SAMER(细菌）

NR-45864??Staphylococcus aureus, SA MER(Bacteria)|Staphylococcus aureus|SA MER|-60°C or colder|NARSAAcknowledgment for publications should read "The following reagent was provided by the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) for distribution by BEI Resources, NIAID, NIH: Staphylococcus aureus, Strain SA MER, NR-45864."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.Staphylococcus aureus (S. aureus), strain SA MER (also referred to as NRS11) was isolated in December 1998 in France from the eye of a 35-year-old female with spontaneous conjunctivitis who had no history of treatment with antimicrobial agents, including glycopeptides, in the preceding three months.S. aureus, strain SA MER was deposited as a heterogeneous vancomycin-intermediate S. aureus (hVISA) strain, but unlike most hVISA strains, it is susceptible to methicillin. S. aureus, strain SA MER was deposited as resistant to benzylpenicillin; negative for mecA, vanA, vanB, vanC1, vanC2, vanD and vanE; MLST sequencing type (ST) 5; eGenomic spa type 2, eGenomic spa repeats TJMBMDMGMK; Ridom spa type t002. SA MER was the parental strain used to derive strains SA MER-S6 (NRS-12), SA MER-S12 (NRS13) and SA MER-S20 (NRS14) by exposing this strain to increasing levels of vancomycin resulting in the strains growing in the presence of 6 ?g/mL, 12 ?g/mL and 20 ?g/mL vancomycin, respectively.Each vial contains approximately 0.5 mL of bacterial culture in Brain Heart Infusion broth supplemented with 10% glycerol.